Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults

NCT03838497 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Streptococcal Pneumonia
HIV/AIDS

Interventions

BIOLOGICAL: Prevenar13

Sponsor

Korea University Guro Hospital